ANTICONVULSANT ACTIVITY OF LAMOTRIGINE POLYMERIC MICELLE AND SAFRANAL NIOSOMAL FORMULATION AGAINST STRYCHNINE-INDUCED CONVULSION
Journal: Indian Drugs (Vol.53, No. 2)Publication Date: 2016-02-26
Authors : Patil P. J.; Chaudhari S. P.; Patil J. R.; Bhandurge N. B.;
Page : 62-64
Keywords : ;
Abstract
Lamotrigine is currently available as a tablet which is administered 2-3 times per day as divided doses of 25-600 mg. Oral liquid formulations with additional sustained release properties are always preferred for pediatric, geriatric even dysphagic patients, due to their ease of administration and patient compliance even at the time of epileptic attack. Hence, polymeric micelle formulation of lamotrigine and safranol niosomal nasal formulation were studied. Polymeric micelles containing lamotrigine were prepared by direct dissolution technique using block copolymer (Pluronic L81, Pluronic F68) in combination (1:1) ratio. Niosomes containing safranal were prepared by modified ether injection technique using non-ionic surfactants (Span 80 and Tween 20 & 80), gelucire 44/50, pluronic f-127 and cholesterol at different ratios. In this test, strychnine (4 mg/kg) was injected to the animal subcutaneously (s.c.) beneath the loose folds of neck skin. Fifteen minutes post administration of lamotrigine and safranal administration by intravenous route. Animals were observed for 10 min for occurrence and onset on various seizures. Latencies were noted in seconds. The present study is to evaluate anticonvulsant activity of lamotrigine (LTG) polymeric miceller formulation and safranal niosomal formulation on strychnine induced convulsions in mice. Vehicle failed to protect the mice from generalized clonic-tonic convulsions induced by strychnine. Lamotrigine significantly delay the onset of myoclonic, clonic and tonic extensor by all three routes i.e. nasal, intravenous and oral as compared to vehicle group. Effect of lamotrigine by nasal route is similar to the effect by intravenous route. Lamotrigine by nasal and intravenous route have shown more effect when given by oral route. Lamotrigine and safranal significantly delay the onset of myoclonic, clonic and tonic extensor by I.V. route as compared to vehicle group.
Other Latest Articles
- IN VIVO ASSESSMENT OF BIOAVAILABILITY OF SUSTAINED RELEASE MATRIX TABLETS OF AN ANTIHYPERTENSIVE DRUG IN RABBITS USING REVERSE PHASE CHROMATOGRAPHY
- MICROWAVE-ASSISTED FORCED DEGRADATION AND DEVELOPMENT OF A VALIDATED STABILITY-INDICATING RP-HPLC METHOD FOR VENLAFAXINE IN BULK AND CAPSULE FORMULATION
- STABILITY INDICATING OPTIMIZED RP-HPLC METHOD APPLYING QBD PRINCIPLES FOR QUANTITATIVE ESTIMATION OF NIMORAZOLE
- IN VITRO EVALUATION OF TOPICAL GELS CONTAINING CELECOXIB-LOADED STEARIC AND ALGINIC ACIDS-BASED MICROPARTICLES
- DISSOLUTION LINKED IN VITRO LIPASE INHIBITION BY DEVELOPED ORLISTAT FORMULATION
Last modified: 2017-08-23 15:26:42